β受体阻滞剂与高血压治疗  

Application ofβ-blockers for hypertension

作　　者：崔素梅 崔兆强 CUI Sumei;CUI Zhaoqiang(Department of Emergency Medicine,Qilu Hospital of Shandong University,Jinan 250012,China;Department of Cardiology,Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital,Fudan University,Shanghai 200032,China)

机构地区：[1]山东大学齐鲁医院,济南250012 [2]复旦大学附属中山医院,上海200032

出　　处：《中国临床药理学与治疗学》2022年第4期423-427,共5页Chinese Journal of Clinical Pharmacology and Therapeutics

基　　金：国家自然科学基金(82002017)。

摘　　要：β受体阻滞剂是治疗高血压等多种心血管疾病的基础药物之一。但是,近年来有研究质疑甚至否定β受体阻滞剂的降压效益,对部分心血管医生造成了困惑。基于对多项研究的系统分析,笔者认为β受体阻滞剂一线降压地位仍不可动摇,并在本文进行了详细论证。β-blockers are widely administered to patients with various cardiovascular diseases including hypertension.However,in recent years,studies have questioned or even denied the antihypertensive effect ofβ-blockers,which has caused confusion to cardiovascular clinicians.Based on the systematic analysis of a number of studies,the author believes thatβ-blockers still remain the status as the first-line antihypertensives.

关 键 词：Β受体阻滞剂 高血压 抗高血压药物 

分 类 号：R544.1[医药卫生—心血管疾病]